申请人:EXCIVA GmbH
公开号:US20210228508A1
公开(公告)日:2021-07-29
Compounds of Formula I
or enantiomers thereof, metabolites thereof, derivatives thereof, deuterated derivatives thereof, prodrugs thereof, pharmaceutically acceptable salts thereof, N-oxides thereof, or a combination thereof, processes and intermediates for preparation thereof, compositions thereof, and uses thereof, are provided.